Compound: Ponatinib

Drug Target: ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3

Drug Target pathway: Other, kinases

Dataset


Associations from all tissue specific and pan-cancer ANOVA analyses overlaid. Hover the pointer over each circle to reveal the context-specific details of an association.

Retrieving drug sensitivity data...

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.